Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Clinicopathologic assessment and imaging of tauopathies in neurodegenerative dementias.

Murray ME, Kouri N, Lin WL, Jack CR Jr, Dickson DW, Vemuri P.

Alzheimers Res Ther. 2014 Jan 2;6(1):1. doi: 10.1186/alzrt231. eCollection 2014. Review.

2.

Mutations causing neurodegenerative tauopathies.

Goedert M, Jakes R.

Biochim Biophys Acta. 2005 Jan 3;1739(2-3):240-50. Review.

3.

Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies.

Ono M, Sahara N, Kumata K, Ji B, Ni R, Koga S, Dickson DW, Trojanowski JQ, Lee VM, Yoshida M, Hozumi I, Yoshiyama Y, van Swieten JC, Nordberg A, Suhara T, Zhang MR, Higuchi M.

Brain. 2017 Mar 1;140(3):764-780. doi: 10.1093/brain/aww339.

PMID:
28087578
4.

Therapeutic strategies for the treatment of tauopathies: Hopes and challenges.

Khanna MR, Kovalevich J, Lee VM, Trojanowski JQ, Brunden KR.

Alzheimers Dement. 2016 Oct;12(10):1051-1065. doi: 10.1016/j.jalz.2016.06.006. Review.

5.

Tauopathies as clinicopathological entities.

Irwin DJ.

Parkinsonism Relat Disord. 2016 Jan;22 Suppl 1:S29-33. doi: 10.1016/j.parkreldis.2015.09.020. Epub 2015 Sep 8. Review.

6.

The neuropathological spectrum of neurodegenerative tauopathies.

Tolnay M, Probst A.

IUBMB Life. 2003 Jun;55(6):299-305. Review.

7.

Invited review: Neuropathology of tauopathies: principles and practice.

Kovacs GG.

Neuropathol Appl Neurobiol. 2015 Feb;41(1):3-23. doi: 10.1111/nan.12208. Review.

PMID:
25495175
8.

Genetic Disorders with Tau Pathology: A Review of the Literature and Report of Two Patients with Tauopathy and Positive Family Histories.

Tacik P, Sanchez-Contreras M, Rademakers R, Dickson DW, Wszolek ZK.

Neurodegener Dis. 2016;16(1-2):12-21. doi: 10.1159/000440840. Epub 2015 Nov 10. Review.

9.

Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).

Spillantini MG, Van Swieten JC, Goedert M.

Neurogenetics. 2000 Mar;2(4):193-205. Review.

PMID:
10983715
10.
11.
12.

Increased pro-nerve growth factor and decreased brain-derived neurotrophic factor in non-Alzheimer's disease tauopathies.

Belrose JC, Masoudi R, Michalski B, Fahnestock M.

Neurobiol Aging. 2014 Apr;35(4):926-33. doi: 10.1016/j.neurobiolaging.2013.08.029. Epub 2013 Oct 8.

PMID:
24112788
13.

New insights into genetic and molecular mechanisms of brain degeneration in tauopathies.

Forman MS, Lee VM, Trojanowski JQ.

J Chem Neuroanat. 2000 Dec;20(3-4):225-44. Review.

PMID:
11207421
14.

Specific profile of tau isoforms in argyrophylic grain disease.

Rábano A, Cuadros R, Calero M, Hernández F, Avila J.

J Exp Neurosci. 2013 Sep 12;7:51-9. doi: 10.4137/JEN.S12202. eCollection 2013.

15.

Sporadic Pick's disease: a tauopathy characterized by a spectrum of pathological tau isoforms in gray and white matter.

Zhukareva V, Mann D, Pickering-Brown S, Uryu K, Shuck T, Shah K, Grossman M, Miller BL, Hulette CM, Feinstein SC, Trojanowski JQ, Lee VM.

Ann Neurol. 2002 Jun;51(6):730-9.

PMID:
12112079
16.

Tau-based treatment strategies in neurodegenerative diseases.

Schneider A, Mandelkow E.

Neurotherapeutics. 2008 Jul;5(3):443-57. doi: 10.1016/j.nurt.2008.05.006. Review.

17.

[Dynamic neuropathology of tauopathy].

Murayama S.

Rinsho Shinkeigaku. 2001 Dec;41(12):1101-3. Review. Japanese.

PMID:
12235808
18.

Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies.

Irwin DJ, Cohen TJ, Grossman M, Arnold SE, Xie SX, Lee VM, Trojanowski JQ.

Brain. 2012 Mar;135(Pt 3):807-18. doi: 10.1093/brain/aws013.

20.

Biochemistry and molecular biology of tauopathies.

Hasegawa M.

Neuropathology. 2006 Oct;26(5):484-90. Review.

PMID:
17080729

Supplemental Content

Support Center